Načítá se...
Development of a predictive model for stromal content in prostate cancer samples to improve signature performance
Prostate cancer is heterogeneous in both cellular composition and patient outcome, and development of biomarker signatures to distinguish indolent from aggressive tumours is a high priority. Stroma plays an important role during prostate cancer progression and undergoes histological and transcriptio...
Uloženo v:
| Vydáno v: | J Pathol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900085/ https://ncbi.nlm.nih.gov/pubmed/31206668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.5315 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|